Anastrozole is a non-steroidal aromatase inhibitor that decreases estrogen synthesis by blocking aromatase activity. This mechanism makes it particularly relevant to estrogen-dependent breast cancer.
Arimidex is principally used as endocrine therapy for certain hormone-receptor-positive breast cancers, especially in postmenopausal women. Its use can occur during initial, adjuvant, or advanced-disease treatment depending on the clinical plan.
The supplied formulation contains 1mg tablets. Prolonged estrogen suppression may contribute to musculoskeletal symptoms and reduced bone mineral density, alongside other endocrine effects.
Reviews
There are no reviews yet.